Viewing nowCombinationTrevel Tablet 40/5/10 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201802584 · Approved 2018.06.20 · Insurance code 693902840
Treatment of hypertension and dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used for patients with essential hypertension who are either on a combination of Telmisartan and Amlodipine or who have difficulty controlling blood pressure. Additionally, Rosuvastatin is used as an adjunct in cases of hypercholesterolemia or familial hypercholesterolemia and dyslipidemia that are not controlled by diet and exercise. Rosuvastatin lowers total cholesterol and LDL cholesterol, delaying the progression of atherosclerosis and helping to reduce cardiovascular disease risk. Particularly, it reduces the risk of stroke, myocardial infarction, and vascular revascularization in men over 50 and women over 60 who have additional cardiovascular risk factors. Therefore, this medication is effectively used to manage hypertension and hyperlipidemia.
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking telmisartan/amlodipine combination therapy together with rosuvastatin as a single agent, they may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before starting the telmisartan/amlodipine combination, it is recommended that the dose of the individual components (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Since systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. In a drug interaction study of the active ingredients in this medicine, telmisartan/amlodipine 80/10 mg and rosuvastatin 20 mg, rosuvastatin Cmax increased approximately 2.4-fold and AUC approximately 1.3-fold in the presence of telmisartan/amlodipine. Therefore, when administering this medicine, assess the potential risk due to the increase in rosuvastatin Cmax and monitor patients closely.
This medication can cause severe harm to the fetus if taken during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. This medication should not be used in patients with allergies to any of its active ingredients or related components or those with specific diseases. Patients with severe liver or kidney impairment, certain heart conditions, and a history of vascular edema should not take this medication. Elderly patients, patients with slightly impaired liver function, or those with hyperkalemia should use this medication with caution and require regular monitoring. This medication can cause musculoskeletal adverse reactions such as myalgia and myopathy, so if muscle pain or weakness occurs while taking it, consult a doctor immediately. Furthermore, this medication may affect liver function, so it is important to periodically check liver enzyme levels. Interactions may occur when taken with other medications, so inform your doctor of any other medications you are currently taking. Particularly, caution is needed as the blood concentration of this medication may increase with certain drugs, raising the risk of side effects. This medication is not recommended for nursing women, and it is important to avoid getting pregnant while taking it. In case of overdose, symptoms such as hypotension, dizziness, and cardiac dysfunction may occur, and you should contact a medical institution immediately for appropriate treatment. The safety and efficacy of this medication in children have not been sufficiently established, so its use is not recommended. When taking this medication, keep it out of reach of children and do not transfer it to another container.
Viral upper respiratory tract infection, dyspnea, anal bleeding, dyspepsia, atopic dermatitis, peripheral edema, chronic gastritis, hiatal hernia, musculoskeletal pain, neck pain, nasopharyngitis, upper abdominal discomfort, upper abdominal pain, position-related dizziness, dysuria, rhinitis, oropharyngeal discomfort, lung disease, unspecified intestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, decreased sensation, movement disorder, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory infection, low back pain, sinusitis, diarrhea, pharyngitis, erectile dysfunction, increased sweating, flushing, allergy, fever, leg pain, fatigue, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, dizziness, sensory abnormalities, involuntary muscle contractions, decreased sensation, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disease, gout, hypercholesterolemia, diabetes, arthritis, arthralgia, leg numbness, anxiety, depression, nervousness, infection, fungal infection, abscess, otitis media, asthma, bronchitis, rhinitis, epistaxis, dermatitis, rash, eczema, pruritus, vascular edema, polymorphic exanthema, papular rash, visual disturbances, conjunctivitis, diplopia, ocular pain, ear pain, frequent urination, urinary disorders, nocturia, dry mouth, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, headache, fatigue, abdominal pain, drowsiness, arrhythmia, bradycardia, chest pain, peripheral ischemia, syncope, orthostatic hypotension, vasculitis, peripheral neuropathy, tremors, appetite loss, dysphagia, pancreatitis, vomiting, gingival hyperplasia, allergic reaction, burning sensation, fatigue, rigidity, weight gain, weight loss, arthrosis, muscle cramps, myalgia, sexual dysfunction, insomnia, abnormal dreams, depersonalization, eosinophilia, thrombocytopenia, increased uric acid, liver function abnormalities, liver disease, acute renal failure, anemia, elevated CPK, anaphylactic reaction, tendon pain, rhabdomyolysis, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, memory loss, weakness, myalgia, myopathy, myositis, headache, dizziness, constipation, nausea, abdominal pain, pruritus, rash, urticaria, myopathy, rhabdomyolysis, weakness, dysuria, rhinitis, oropharyngeal discomfort, lung disease, unspecified intestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, decreased sensation, movement disorder, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a special container that blocks light. Additionally, it should be kept at a temperature between 1 degree and 30 degrees Celsius to maintain its effectiveness.
Pink oval film-coated tablet
30 tablets (10 tablets x 3)/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.